Page last updated: 2024-10-25

deferoxamine and Corneal Diseases

deferoxamine has been researched along with Corneal Diseases in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Corneal Diseases: Diseases of the cornea.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morad, Y1
Banin, E1
Averbukh, E1
Berenshtein, E1
Obolensky, A1
Chevion, M1

Other Studies

1 other study available for deferoxamine and Corneal Diseases

ArticleYear
Treatment of ocular tissues exposed to nitrogen mustard: beneficial effect of zinc desferrioxamine combined with steroids.
    Investigative ophthalmology & visual science, 2005, Volume: 46, Issue:5

    Topics: Animals; Atrophy; Burns, Chemical; Chemical Warfare Agents; Corneal Diseases; Corneal Neovasculariza

2005